camptothecin has been researched along with as 1411 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Abnous, K; Alibolandi, M; Farzad, SA; Hosseini Shamili, F; Ramezani, M; Ramezani, P; Taghdisi, SM | 1 |
Li, J; Li, S; Liu, Y; Lu, D; Shan, Y; Yang, G; Yang, Y; Zhang, Q | 1 |
2 other study(ies) available for camptothecin and as 1411
Article | Year |
---|---|
Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Aptamers, Nucleotide; Camptothecin; Cell Line, Tumor; CHO Cells; Colon; Colonic Neoplasms; Cricetulus; Dendrimers; Drug Carriers; Drug Delivery Systems; HT29 Cells; Humans; Mice; Mice, Inbred BALB C; Nanoparticles; Nucleolin; Oligodeoxyribonucleotides; Phosphoproteins; RNA-Binding Proteins | 2017 |
Dynamics of delivering aptamer targeted nano-drugs into cells.
Topics: A549 Cells; Animals; Aptamers, Nucleotide; Camptothecin; Chlorocebus aethiops; Drug Delivery Systems; Humans; Molecular Structure; Nanoparticles; Oligodeoxyribonucleotides; Optical Imaging; Particle Size; Polyamines; Surface Properties; Vero Cells | 2021 |